In clinically manifested depression, circulating endothelial and progenitor cells, the plasma levels of soluble VWF, and VCAM-1 were altered in major depressive patients, and these biomarkers were normalized after antidepressant treatment, indicating the reversibility of endothelial dysfunction in major depression [29]. This evidence concerns the gene VWF and depressive symptom measurement.